03:54 PM EDT, 08/14/2025 (MT Newswires) -- Health care stocks advanced late Thursday afternoon, with the NYSE Health Care Index gaining 0.7% and the Health Care Select Sector SPDR Fund (XLV) adding 0.5%.

The iShares Biotechnology ETF (IBB) increased 0.2%.

In corporate news, uniQure (QURE) shares jumped 8.1% after Mizuho upgraded the stock to outperform from neutral and raised its price target to $30 from $20.

ScPharmaceuticals ( SCPH ) shares climbed 4% after the company received five notices of allowance from the US Patent and Trademark Office for patent applications covering its SCP-111 furosemide formulation.

Novartis ( NVS ) and Roche executives met with Swiss government officials to discuss the outlook for the pharmaceutical industry following the imposition of an additional 39% tariff on Swiss exports to the US, multiple media reports said. Novartis ( NVS ) shares added 0.9%.

Eli Lilly ( LLY ) shares rose 3.4% after the company said it will increase the UK price of its weight-loss and type 2 diabetes drug Mounjaro starting in September for alignment with other developed countries.

Trinity Biotech ( TRIB ) shares surged 82% after the company received approval from the New York State Department of Health to start providing its PreClara Ratio biomarker test for the assessment of preeclampsia risk.